NRAS mutations with low allele burden have independent prognostic significance for patients with lower risk myelodysplastic syndromes

Leukemia. 2013 Oct;27(10):2077-81. doi: 10.1038/leu.2013.160. Epub 2013 May 27.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • DNA Mutational Analysis
  • DNA Primers / chemistry
  • DNA Primers / genetics
  • GTP Phosphohydrolases / genetics*
  • Humans
  • Membrane Proteins / genetics*
  • Mutation / genetics*
  • Myelodysplastic Syndromes / genetics*
  • Myelodysplastic Syndromes / mortality
  • Polymerase Chain Reaction
  • Prognosis
  • Risk Factors
  • Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
  • Survival Rate

Substances

  • DNA Primers
  • Membrane Proteins
  • GTP Phosphohydrolases
  • NRAS protein, human